Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Federal Trade Commission
Moodys
Argus Health
Julphar
Covington
Dow
Farmers Insurance
Harvard Business School
Novartis

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,731,478

« Back to Dashboard

Summary for Patent: 4,731,478
Title: Sulfamoyl-substituted phenethylamine derivatives, their preparation, and pharmaceutical compositions, containing them
Abstract:A novel process is provided for the preparation of optical isomers of certain sulfamoyl-substituted phenethylamine derivatives which exhibit .alpha.-adrenergic blocking agents which can be used for various treatments such as for the treatment of congestive heart failure.
Inventor(s): Niigata; Kunihiro (Saitama, JP), Fujikura; Takashi (Saitama, JP)
Assignee: Yamanouchi Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:06/803,204
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 4,731,478

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,731,478

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan55-14382Feb 08, 1980

International Patents Family Members for US Patent 4,731,478

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 227533 ➤ Subscribe
Argentina 230433 ➤ Subscribe
Austria 7223 ➤ Subscribe
Australia 541720 ➤ Subscribe
Australia 6689681 ➤ Subscribe
Canada 1177849 ➤ Subscribe
Germany 19675042 ➤ Subscribe
Germany 3163257 ➤ Subscribe
European Patent Office 0034432 ➤ Subscribe SPC/GB96/017: EXPIRE United Kingdom ➤ Subscribe
European Patent Office 0034432 ➤ Subscribe 96C0048 Belgium ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Dow
Moodys
Teva
Harvard Business School
US Department of Justice
Novartis
Federal Trade Commission
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot